Amanda E Janitz1, Barbara R Neas1, Janis E Campbell1, Anne E Pate2, Julie A Stoner1, Sheryl L Magzamen3, Jennifer D Peck1. 1. Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. 2. School of Nursing and Allied Health Sciences, Southwestern Oklahoma State University, Weatherford, Oklahoma. 3. Department of Environmental and Radiological Health Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado.
Abstract
BACKGROUND: Data-linkage studies have reported an association between congenital anomalies and childhood cancer. However, few studies have focused on the differences in the effect of congenital anomalies on cancer as a function of attained age. We aimed to examine associations between anomalies and childhood cancer as a function of attained age among children born in Oklahoma. METHODS: Data were obtained from the Oklahoma State Department of Health from 1997 to 2009 (n = 591,235). We linked Vital Statistics records for singleton deliveries to the Oklahoma Birth Defects Registry and the Oklahoma Central Cancer Registry using name and birth date. To assess the relation between anomalies and childhood cancer, we used Cox regression analysis allowing for a nonproportional hazards for anomalies as a function of age. RESULTS: There were 23,368 (4.0%) children with anomalies and 531 (0.1%) children with cancer. When considering 3-year age intervals, we detected an increased hazard of any childhood cancer in children with anomalies compared with those without anomalies before 1 year of age (hazard ratio, 14.1; 95% confidence interval, 8.3-23.7) and at 3 years of age (hazard ratio, 2.3; 95% confidence interval, 1.6-3.2). The increased hazard declined with increasing time since birth, with the effect diminished by 6 years of age. CONCLUSION: Our results were consistent with previous studies indicating an increased rate of childhood cancer among children with anomalies at younger ages. Furthermore, our study added a methodological refinement of assessing the effect of anomalies as a function of attained age. Birth Defects Research (Part A) 106:633-642, 2016.
BACKGROUND: Data-linkage studies have reported an association between congenital anomalies and childhood cancer. However, few studies have focused on the differences in the effect of congenital anomalies on cancer as a function of attained age. We aimed to examine associations between anomalies and childhood cancer as a function of attained age among childrenborn in Oklahoma. METHODS: Data were obtained from the Oklahoma State Department of Health from 1997 to 2009 (n = 591,235). We linked Vital Statistics records for singleton deliveries to the Oklahoma Birth Defects Registry and the Oklahoma Central Cancer Registry using name and birth date. To assess the relation between anomalies and childhood cancer, we used Cox regression analysis allowing for a nonproportional hazards for anomalies as a function of age. RESULTS: There were 23,368 (4.0%) children with anomalies and 531 (0.1%) children with cancer. When considering 3-year age intervals, we detected an increased hazard of any childhood cancer in children with anomalies compared with those without anomalies before 1 year of age (hazard ratio, 14.1; 95% confidence interval, 8.3-23.7) and at 3 years of age (hazard ratio, 2.3; 95% confidence interval, 1.6-3.2). The increased hazard declined with increasing time since birth, with the effect diminished by 6 years of age. CONCLUSION: Our results were consistent with previous studies indicating an increased rate of childhood cancer among children with anomalies at younger ages. Furthermore, our study added a methodological refinement of assessing the effect of anomalies as a function of attained age. Birth Defects Research (Part A) 106:633-642, 2016.
Authors: Somer Dawson; Adrian K Charles; Carol Bower; Nicholas H de Klerk; Elizabeth Milne Journal: Birth Defects Res A Clin Mol Teratol Date: 2015-03-24
Authors: Glenn M Marshall; Daniel R Carter; Belamy B Cheung; Tao Liu; Marion K Mateos; Justin G Meyerowitz; William A Weiss Journal: Nat Rev Cancer Date: 2014-03-06 Impact factor: 60.716
Authors: Kimberly J Johnson; Jong Min Lee; Kazi Ahsan; Hannah Padda; Qianxi Feng; Sonia Partap; Susan A Fowler; Todd E Druley Journal: PLoS One Date: 2017-07-27 Impact factor: 3.240
Authors: Quinn T Ostrom; Maral Adel Fahmideh; David J Cote; Ivo S Muskens; Jeremy M Schraw; Michael E Scheurer; Melissa L Bondy Journal: Neuro Oncol Date: 2019-11-04 Impact factor: 12.300
Authors: Erin L Marcotte; Jeremy M Schraw; Tania A Desrosiers; Wendy N Nembhard; Peter H Langlois; Mark A Canfield; Robert E Meyer; Sharon E Plon; Philip J Lupo Journal: JNCI Cancer Spectr Date: 2020-06-11
Authors: Marlena S Norwood; Philip J Lupo; Eric J Chow; Michael E Scheurer; Sharon E Plon; Heather E Danysh; Logan G Spector; Susan E Carozza; David R Doody; Beth A Mueller Journal: PLoS One Date: 2017-06-08 Impact factor: 3.240
Authors: Dagrun Slettebø Daltveit; Kari Klungsøyr; Anders Engeland; Anders Ekbom; Mika Gissler; Ingrid Glimelius; Tom Grotmol; Laura Madanat-Harjuoja; Anne Gulbech Ording; Solbjørg Makalani Myrtveit Sæther; Henrik Toft Sørensen; Rebecca Troisi; Tone Bjørge Journal: BMJ Date: 2020-12-02
Authors: Jeremy M Schraw; Tania A Desrosiers; Wendy N Nembhard; Peter H Langlois; Robert E Meyer; Mark A Canfield; Sonja A Rasmussen; Tiffany M Chambers; Logan G Spector; Sharon E Plon; Philip J Lupo Journal: Cancer Date: 2020-05-29 Impact factor: 6.860
Authors: Barbara Luke; Morton B Brown; Hazel B Nichols; Maria J Schymura; Marilyn L Browne; Sarah C Fisher; Nina E Forestieri; Chandrika Rao; Mahsa M Yazdy; Susan T Gershman; Mary K Ethen; Mark A Canfield; Melanie Williams; Ethan Wantman; Sergio Oehninger; Kevin J Doody; Michael L Eisenberg; Valerie L Baker; Philip J Lupo Journal: JAMA Netw Open Date: 2020-10-01